Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Conference News EuroPCR 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

L.A. McKeown

May 21, 2021

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

News Industry News

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

February 01, 2016

Presentation TCT 2013

Niche Role, Given Their Less Forgiving Nature, Greater Cost, and Lack of Proven Clinical Benefit!

Presenter: David Hildick-Smith

October 27, 2013

Presentation TCT 2013

Gender impact on patients treated with drug-eluting stents – 3 year follow-up data.

Presenter: Fazilatum Nesa Malik, William Wijns, Dezs? APR?, G?rard Finet, JACQUES MONSEGU, Damras Tresukosol, David Hildick-Smith, Ciro Indolfi, Amerigo Stabile, Gian Battista Danzi

January 31, 2013

Presentation TCT 2013

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

Presenter: Jean Fajadet, Eulogio Garcia, David Hildick-Smith, Sonia Petronio, Sigmund Silber, Franz-Josef Neumann, Azfar Zaman, Jochen W?hrle, Mark Spence, simon elhadad

January 31, 2013

Presentation TCT 2012

New Generation Drug Eluting Stent Nobori: 2 Year Clinical Outcome of Patients with Chronic Total Occlusion.

Presenter: Bernard Chevalier, Dragan Sagic, Carlo Trani, Damras Tresukosol, Peep Laanmets, Mario Lombardi, Enrique Novo Garcia, Stefan Hoffmann, Harald Schwacke, Werner Jung, David Hildick-Smith, Gian Battista Danzi

January 03, 2012

Presentation TCT 2012

Are Results from an All-Comers Registry Comparable with the Results from an All-Comers Randomized Clinical Trial? Insights from 12-Month Results of the e-BioMatrix PMS Registry.

Presenter: Philip Urban, Imad Al-Haddad, Jean Jacques Berland, Franz Eberli, Magdi El-Omar, Jean-Jacques Goy, David Hildick-Smith, David G. Iosseliani, Franz-Xaver Kleber, Keith Oldroyd, Giovanni B. Pedrazzini, Marco Roffi, Mariano Vald?s, Stephan Windecker

January 03, 2012

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

Advertisement

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Medtronic Adds New Resolute Onyx(TM) Drug-Eluting Stent Sizes and Expands Indications

Niche Role, Given Their Less Forgiving Nature, Greater Cost, and Lack of Proven Clinical Benefit!

Gender impact on patients treated with drug-eluting stents – 3 year follow-up data.

A Prospective Randomized Multi-center Trial to Assess the Everolimus-Eluting Stent System (Promus Element) for Coronary Revascularization in a Population of Unrestricted Patients

New Generation Drug Eluting Stent Nobori: 2 Year Clinical Outcome of Patients with Chronic Total Occlusion.

Are Results from an All-Comers Registry Comparable with the Results from an All-Comers Randomized Clinical Trial? Insights from 12-Month Results of the e-BioMatrix PMS Registry.

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content